Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEP-ETU in metastatic breast cancer
NCT01190982Phase 2Completed
- Sponsor
- Insys Therapeutics
- Start
- Mar 2008
- Primary completion
- Dec 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liposomal paclitaxel in breast cancer, sponsored by Insys Therapeutics. Primary endpoint: Overall Response Rate at 2 years. Started Mar 2008; status: completed.
02
Drugs
liposomal paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01190982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190982.